KL and anemia: The potential for α-klotho to serve as a biomarker of kidney function has been suggested in recent decades on the basis of reduced renal production of α-klotho in patients with CKD [16–18]; moreover, reduced levels of sKL are reportedly associated with the prevalence of anemia in patients with CKD [19].